Roxithromycin/Ambroxol Hydrochloride

罗红霉素/盐酸氨溴索

Report date: 2026/03/04 20:01:44

Base Information

Drug NameRoxithromycin/Ambroxol Hydrochloride
Drug Alias Name罗红霉素氨溴索复方罗红霉素
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibioticsSmall molecules > Heterocyclic drugs
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsTracheobronchomegalyAsthmaTracheitis +[8] 
Global Approved IndicationsBronchitis, ChronicBronchitis
Approved Indications in ChinaBronchitis, ChronicBronchitis
Original Approved Country/TerritoryMainland China
Original Approved Date2010/01/15
Country/TerritoryMainland China
CombinationsYes RoxithromycinAmbroxol Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Luoxin Pharmaceutical Group Stock Co LtdJiangsu Yabang Epson Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Yabang Epson Pharmaceutical Co Ltd
Inactive CompaniesFuren Pharmaceutical Group Co LtdHefei Chuandi Pharmaceutical Technology Co Ltd
Active IndicationsBronchitis, ChronicBronchitis
Inactive IndicationsTracheobronchomegalyAsthmaTracheitis +[6] 

Other Information

ATC CodeJ01FA06R05CB06
Related LinksN/A